4//SEC Filing
Talecris Biotherapeutics Holdings Corp. 4
Accession 0001225208-11-011296
CIK 0001405197operating
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:53 PM ET
Size
6.3 KB
Accession
0001225208-11-011296
Insider Transaction Report
Form 4
LYNCH THOMAS J
Sr. VP, Corp. Compliance
Transactions
- Award
Common Stock
2011-04-01+1,936→ 4,567 total - Tax Payment
Common Stock
2011-04-01$26.94/sh−912$24,569→ 3,655 total
Footnotes (2)
- [F1]The transaction reported in this row involves the settlement of performance share units into common stock that were granted pursuant to our 2009 Long-Term Incentive Plan.
- [F2]Includes restricted share units representing the right to receive 1,754 shares of the Issuer's common stock that will vest in equal annual installments on April 1, 2012 and April 1, 2013, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001405197
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:53 PM ET
- Size
- 6.3 KB